New legislation introduced this week in the US Senate would make ACA expanded subsidies permanent. Employers expect an increase in per employee healthcare benefit spend in 2025, according to a new survey. And, EHR giant Epic sued over allegations of anticompetitive business practices. We’ll get that story and more coming up on today’s episode of the Gist Healthcare podcast. Hosted on Acast. See acast.com/privacy for more information.

A bill introduced in Congress would exempt some smaller drugmakers from the Medicare drug price negotiation process. The Federal Trade Commission sues the nation’s largest pharmacy benefit managers over the cost of insulin.  And, consumers will be able to self-administer a nasal flu vaccine next year. We’ll get that story—and more—coming up on today’s episode of the Gist Healthcare podcast.  Hosted on Acast. See acast.com/privacy for more information.

A move to extend pandemic-era telehealth and hospital-at-home flexibilities passes out of a key Congressional committee.  Another major health insurer plans to scale back their Medicare Advantage offerings for the upcoming plan year.  And, drug overdose deaths in the US are declining rapidly, according to data from the CDC. We’ll get that story--and more--coming up on today’s episode of the Gist Healthcare podcast. Hosted on Acast. See acast.com/privacy for more information.

The Health Resources and Services Administration threatens sanctions against Johnson & Johnson over the company’s decision to change how hospitals are provided 340B discounts on some prescription drugs.  And, a summer surge of COVID infections could be abating...We’ll get that story—and more—coming up on today’s episode of the Gist Healthcare podcast.  Hosted on Acast. See acast.com/privacy for more information.

Rural hospitals are reportedly not taking advantage of free help from technology companies. A major pharmacy benefit manager sues the Federal Trade Commission over a recent...damning report of the business.  And, a new survey indicates that the physician shortage could be getting worse. We’ll get that story—and more—coming up on today’s episode of the Gist Healthcare podcast.  Hosted on Acast. See acast.com/privacy for more information.

UnitedHealthcare unveils a new “gold card” program for providers to make the prior authorization process more efficient. The Centers for Medicare and Medicaid Services suspends two ACA platforms over concerns that foreign entities had access to consumer information. And, the FDA OKs the first over-the-counter hearing aid software for use with Apple Air Pods. We’ll get that story—and more—coming up on today’s episode of the Gist Healthcare podcast.  Hosted on Acast. See acast.com/privacy...

Healthcare was a hot topic during this week’s presidential debate...especially the past and potential future of the Affordable Care Act. The data of nearly 1 million Medicare beneficiaries could have been exposed to hackers through a software vulnerability discovered last year. And, hospitals experienced a slight labor rebound in August. Those stories and more coming up on today’s episode of the Gist Healthcare podcast. Hosted on Acast. See acast.com/privacy for more information.

The Biden Administration finalizes new mental health parity rules for insurers. A large-scale study suggests that the active ingredient in the blockbuster weight loss medicine Ozempic reduced the risk of severe COVID reactions among patients with obesity. And, we’ll get some more top news in heathcare. That's coming up on today's episode of the Gist Healthcare podcast. Hosted on Acast. See acast.com/privacy for more information.

Several high-ranking executives at Walgreens are being sued by a shareholder as the retail pharmacy’s stock price continues to drop. Humana will exit 13 Medicare Advantage marketplaces ahead of the 2025 plan year.  And, we’ll get some more top healthcare news headlines. That’s coming up on today’s episode of the Gist Healthcare podcast. Hosted on Acast. See acast.com/privacy for more information.

Johnson & Johnson draws the ire of hospitals and the government over a planned change to how it will provide discounts for some of its 340B-eligible drugs. Pfizer becomes the second drug company to get into the direct-to-consumer market. Those stories and more coming up on today’s episode of the Gist Healthcare podcast. Hosted on Acast. See acast.com/privacy for more information.

Struggling Steward Health Care will sell six of its Massachusetts hospitals. Kaiser Permanente backed Risant Health plans to invest more than $1 billion dollars in Cone Health. And, pharmacy benefit manager leaders could be in hot water following testimony over their business practices on Capitol Hill. That’s coming up on today’s episode of the Gist Healthcare podcast.  Hosted on Acast. See acast.com/privacy for more information.

A new report projects the average cost of employer-sponsored health plans to rise 9 percent next year. The Centers for Medicare and Medicaid Services receives 12,000-plus complaints about No Surprises noncompliance. And, the FDA approves a chemo-free treatment for a common type of lung cancer. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

A federal judge blocks the FTC’s ban on noncompetes. And, New Jersey’s governor says about $100 million dollars in residents’ medical debt will be eliminated. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

Massachusetts’ governor arranges deals to force the sale of five Steward Health Care hospitals in the state. As Medicare Advantage enrollment grows, a new report warns of the program’s impact on hospital margins. And Eili Lilly's GLP-1 weight-loss drug reduces the risk of developing type 2 diabetes. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

A Texas court overturns a HHS change to how Medicare pays hospitals that serve large numbers of low-income patients. Medical-cost fiduciary litigation is on the rise. And the FDA authorizes the first over-the-counter, at-home syphilis test. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

Biden’s nursing home staffing mandate gets hit with another lawsuit. This one from the Texas attorney general. Eli Lilly takes action to halt the sales of copycats of its GLP-1 drugs. And Kentucky is the first state to decriminalize medical errors. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

CMS releases results from its first Medicare prescription drug price negotiations under a new federal program. The WHO declares mpox a global public health emergency. And Elevance Health closes a deal with a private equity firm to create a primary care company. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

Steward Health Care signs a definitive agreement to sell its physician group. President Biden announces $150 million dollars in federal awards as part of his “cancer moonshot.” And with no federal AI guidelines on the books, states create their own. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

The FDA approves the first nasal spray formulation to treat anaphylaxis. A report finds that U.S. not-for-profit healthcare providers’ days cash on hand hit a 10-year low. And all eligible hospitals in North Carolina opt into the state’s new medical debt relief program. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

A medical journal retracts three papers on MDMA-assisted psychotherapy following the FDA’s rejection of the treatment. CMS outlines updates for its ACO REACH model for 2025. And the DOJ finalizes a rule to improve access to medical care for people with disabilities. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

A federal judge dismisses a lawsuit over the Medicare drug price negotiation program. Provisional data show that COVID has dropped to the 10th leading cause of death in the U.S. And a recent poll finds that fewer Americans view childhood vaccinations as “important.” That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

CMS finalizes a policy that creates a faster pathway to reimbursement for “breakthrough” medical devices. The FDA approves Purdue Pharma’s opioid overdose-reversal device. And a recent report finds that untreated vision loss and high cholesterol could be risk factors for dementia. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

Providers receive a win in the latest appeals court ruling on the No Surprises Act. About 700 rural hospitals are at risk of closing, according to a new report. And a recent survey finds that less than half of Americans trust doctors. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

Tenet Healthcare plans to sell its majority stake in five Alabama hospitals. The FDA now lists Eli Lilly’s blockbuster GLP-1 drugs as “available.” And a new study finds that less than half of patients challenge insurance claim denials. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

CVS is co-locating Oak Street clinics at existing pharmacies. A new Epic feature allows patients to release their medical records to apps of their choice. And a recent study finds that Gen Xers and millennials are more likely to develop certain cancers. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.